MediciNova enters deal to take part in long Covid treatment trial
The trial of MN-166 will commence following regulatory review and finalisation of the protocol.
Covid-19
Latest in
Covid-19
Virios doses first subject in long Covid antiviral trial
IMC-2 merges valacyclovir and celecoxib together to hinder the herpes virus from activating and replicating.
AIM ImmunoTech outlines Phase II study plans for long Covid fatigue
AIM ImmunoTech leadership offers new details on a potential Phase II trial of Ampligen in long Covid patients with chronic…
By
Ashvattha previews plans for long Covid trial in mid-2023
In an exclusive, Ashvattha Therapeutics CEO Jeff Cleland discusses a potential trial of OP-101 in long Covid patients experiencing chronic…
By
Frontier reports positive Phase I Covid-19 drug data
In the trial, up to 400mg daily dose of FB2001 was found to be safe and well tolerated.
Novavax begins Phase IIb/III Covid-19 vaccine trial in children
The trial will enrol 3,600 participants in Mexico, US, Argentina, Spain, UK, Colombia, South Africa, Philippines and Brazil.
Ascletis receives FDA nod for Phase Ib Covid-19 oral drug trial
The trial will analyse the safety, tolerability, pharmacokinetics and initial efficacy of ASC10 tablets in Covid-19 patients.
DCRI tasked as data centre for NIH long Covid studies
The institute will partner with RTI International to expedite the trial process and launch multi-intervention studies.